Circulation: Heart Failure

Hemodynamic Effects of Sacubitril-Valsartan Versus Enalapril in Patients with Heart Failure in the EVALUATE-HF Study: Effect Modification by Left Ventricular Ejection Fraction and Sex.  352-360. 2021

Response by Unlu et al to Letter Regarding Article, "polypharmacy in Older Adults Hospitalized for Heart Failure".  429-430. 2021

Inflammation and Circulating Natriuretic Peptide Levels.  13:135-144. 2020

Assessment of Heterogeneity in Heart Failure-Related Meta-Analyses.  655-659. 2020

Association of Sedentary Time and Incident Heart Failure Hospitalization in Postmenopausal Women.  757-766. 2020

Lower Rates of Heart Failure and All-Cause Hospitalizations during Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes from the CardioMEMS Post-Approval Study.  229-238. 2020

Polypharmacy in Older Adults Hospitalized for Heart Failure.  577-588. 2020

Prognostic Awareness and Goals of Care Discussions among Patients with Advanced Heart Failure.  326-333. 2020

Characteristics and healthcare utilization among veterans treated for heart failure with reduced ejection fraction who switched to sacubitril/valsartan.  12. 2019

Intra-aortic Balloon Pump As a Bridge to Heart Transplant after Non-ST-Segment-Elevation Myocardial Infarction in Palliated Hypoplastic Left Heart Syndrome.  12. 2019

Prevalence of American Heart Association Heart Failure Stages in Black and White Young and Middle-Aged Adults: The CARDIA Study.  12. 2019

IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients With Heart Failure.  11:e005133. 2018

Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial.  11:e004457. 2018

Predicting Risk in Patients Hospitalized for Acute Decompensated Heart Failure and Preserved Ejection Fraction: The Atherosclerosis Risk in Communities Study Heart Failure Community Surveillance.  10. 2017

Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis.  10. 2017

Myocardial Upregulation of Cathepsin D by Ischemic Heart Disease Promotes Autophagic Flux and Protects Against Cardiac Remodeling and Heart Failure.  10. 2017

Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial.  10. 2017

Activated T lymphocytes are essential drivers of pathological remodeling in ischemic heart failure.  10. 2017

Intracardiac Pressures Measured Using an Implantable Hemodynamic Monitor: Relationship to Mortality in Patients with Chronic Heart Failure.  10. 2017

Dying with a Left Ventricular Assist Device as Destination Therapy.  9. 2016

Association of weight and body composition on cardiac structure and function in the ARIC study (Atherosclerosis Risk in Communities).  9. 2016

Pulmonary Artery Pressure-Guided Heart Failure Management Reduces 30-Day Readmissions.  9. 2016

Heart failure and midrange ejection fraction.  9. 2016

Prognostic relevance of left atrial dysfunction in heart failure with preserved ejection fraction.  9. 2016

Clinical Characteristics and Outcomes of Intravenous Inotropic Therapy in Advanced Heart Failure.  8:880-886. 2015

Duration of Heart Failure Is an Important Predictor of Outcomes after Mechanical Circulatory Support.  8:953-959. 2015

Response to Letter Regarding Article, "cardiac Structure and Function Across the Glycemic Spectrum in Elderly Men and Women Free of Prevalent Heart Disease: The Atherosclerosis Risk in the Community Study".  8:1010. 2015

Alcohol and Incident Heart Failure among Middle-Aged and Elderly Men: Cohort of Swedish Men.  8:422-427. 2015

Cardiac Structure and Function Across the Glycemic Spectrum in Elderly Men and Women Free of Prevalent Heart Disease: The Atherosclerosis Risk in the Community Study.  8:448-454. 2015

Central cardiac limit to aerobic capacity in patients with exertional pulmonary venous hypertension: Implications for heart failure with preserved ejection fraction.  8:278-285. 2015

Characteristics and outcomes of patients with advanced chronic systolic heart failure receiving care at the veterans affairs versus other hospitals insights from the Beta-blocker Evaluation of Survival Trial (BEST).  8:17-24. 2015

Derivation and high engraftment of patient-specific cardiomyocyte sheet using induced pluripotent stem cells generated from adult cardiac fibroblast.  8:156-166. 2015

Discharge hospice referral and lower 30-day all-cause readmission in medicare beneficiaries hospitalized for heart failure.  8:733-740. 2015

E/e′ ratio in patients with unexplained dyspnea lack of accuracy in estimating left ventricular filling pressure.  8:749-756. 2015

Effects of intracoronary infusion of escalating doses of cardiac stem cells in rats with acute myocardial infarction.  8:757-765. 2015

Heart Failure Management in Skilled Nursing Facilities: A Scientific Statement from the American Heart Association and the Heart Failure Society of America.  8:655-687. 2015

Prognostic Importance of Changes in Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone.  8:1052-1058. 2015

Prognostic Significance of Depression in Blacks with Heart Failure: Insights from Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training.  8:497-503. 2015

Risk of heart failure among postmenopausal women a secondary analysis of the randomized trial of Vitamin D plus calcium of the women's health initiative.  8:49-56. 2015

Risk of heart failure and death after prolonged smoking cessation: Role of amount and duration of prior smoking.  8:694-701. 2015

Transitions of care in heart failure: A scientific statement from the American heart association.  8:384-409. 2015

Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction.  7:935-944. 2014

Calcium channel blockers and outcomes in older patients with heart failure and preserved ejection fraction.  7:945-952. 2014

Cardiac structure and function and prognosis in heart failure with preserved ejection fraction.  7:740-751. 2014

Cardiac structure and function in heart failure with preserved ejection fraction: Baseline findings from the echocardiographic study of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial.  7:104-115. 2014

Elevation in high-sensitivity troponin t in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696.  7:953-959. 2014

Increased sarcolipin expression and adrenergic drive in humans with preserved left ventricular ejection fraction and chronic isolated mitral regurgitation.  7:194-202. 2014

Left atrial volume and the benefit of cardiac resynchronization therapy in the MADIT-CRT Trial.  7:154-160. 2014

Metabolomic analysis of pressure-overloaded and infarcted mouse hearts.  7:634-642. 2014

Effects of exercise on left ventricular systolic and diastolic properties in patients with heart failure and a preserved ejection fraction versus heart failure and a reduced ejection fraction.  6:508-516. 2013

Right ventricular function, pulmonary pressure estimation, and clinical outcomes in cardiac resynchronization therapy.  6:435-442. 2013

Mediterranean and DASH diet scores and mortality in women with heart failure the women s health initiative.  6:1116-1123. 2013

Response to letter regarding article, habitual coffee consumption and risk of heart failure: A dose-response meta-analysis.  5. 2012

Anisotropic reinforcement of acute anteroapical infarcts improves pump function.  5:515-522. 2012

Habitual coffee consumption and risk of heart failure a dose-response meta-analysis.  5:401-405. 2012

Coffee consumption and incidence of heart failure in women.  4:414-418. 2011

Dyssynchrony, contractile function, and response to cardiac resynchronization therapy.  4:433-440. 2011

Response to letter regarding article, "chocolate intake and incidence of heart failure: A population-based, prospective study of middle-aged and elderly women".  4. 2011

Chocolate intake and incidence of heart failure a population-based prospective study of middle-aged and elderly women.  3:612-616. 2010

Chronic ambulatory intracardiac pressures and future heart failure events.  3:580-587. 2010

Editorial: Can vitamin D supplementation improve physical function and quality of life in older patients with heart failure?.  3:183-184. 2010

Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease findings from propensity-matched studies.  3:253-260. 2010

Effects of peripheral arterial disease on outcomes in advanced chronic systolic heart failure a propensity-matched study.  3:118-124. 2010

α1-adrenergic receptor subtypes in nonfailing and failing human myocardium.  2:654-663. 2009

Adiposity and incidence of heart failure hospitalization and mortality: A population-based prospective study.  2:202-208. 2009

Reduction in mitral regurgitation during therapy guided by measured filling pressures in the ESCAPE trial.  2:181-188. 2009

Mechanical circulatory support: registering a therapy in evolution..  1:200-205. 2008